STEP2 for Cancer

(STEP2 RNT Trial)

This trial aims to find better ways to provide palliative care, enhancing the quality of life for people with advanced cancer. The study explores two options: early palliative care referrals for everyone or a new system called STEP2 (Virtual and in-person Symptom screening with Targeted Early Palliative care), where referrals occur only if a patient reports moderate to severe symptoms. The researchers aim to determine if STEP2 is as effective as routine care by monitoring patients' well-being and satisfaction over time. People with advanced-stage cancer who experience significant symptoms and are open to online symptom checks might find this trial suitable. As an unphased trial, it offers a unique opportunity to contribute to innovative care strategies that could improve quality of life for future patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that STEP2, which involves checking symptoms and providing specific supportive care, is safe. In earlier studies, most patients completed the symptom checks, with many doing so regularly over several visits. This indicates that the process is generally manageable for patients.

Although the studies do not report specific negative effects from STEP2, the high completion rate suggests that patients do not experience major issues from the checks or subsequent care. Additionally, other research on telehealth palliative care, a component of STEP2, has found it to be as effective as in-person doctor visits, confirming the safety and efficacy of the online component.

Researchers are excited about the STEP2 protocol because it offers a more personalized approach to palliative care for cancer patients. Unlike standard early palliative care, which automatically refers patients for extra support, STEP2 only activates when patients report moderate-to-severe symptoms. This targeted method could ensure that resources are directed more efficiently, potentially improving quality of life for those who need it most. By combining virtual and in-person symptom screenings, STEP2 also provides a flexible, accessible way for patients to receive care tailored to their current needs.

Research has shown that the STEP2 system, a treatment option in this trial, might improve the quality of life for people with advanced cancer. In an earlier study, 77% of patients regularly used the symptom screening tool, and more than half of those with severe symptoms received specialized care to ease their discomfort. This method targets those in greatest need by referring only patients with significant symptoms. Early results suggest that STEP2 is practical and well-received by patients, showing potential for identifying those who would benefit from early supportive care. While more information is needed, it offers a focused way to manage symptoms and improve patient satisfaction. Meanwhile, the Routine Early Palliative Care (EPC) arm automatically provides early palliative care referrals, offering a different approach to managing patient needs.¹²³⁴⁶